Impairment Of Long Lived Assets Held For Use
Impairment of long-lived assets
Impairment, Long-Lived Asset, Held-for-Use, Total
Contingent Consideration by Type [Axis]
Segment Reporting Policy Policy [Text Block]
Segment Reporting
Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Rights
Vesting term
Operating Leases Future Minimum Payments Due In Four Years
2025
Direct costs and expenses.
Direct Costs And Expenses [Member]
Direct Costs and Expenses
Forecast
Forecast [Member]
Vehicles
Vehicles [Member]
Deferred Revenue Arrangement Type [Axis]
Purchase agreement term
Purchase Agreement Term
Purchase agreement term.
Auditor Location
Testing services.
Testing Services [Member]
Testing Services
Operating Expenses [Abstract]
Operating expenses:
Deferred tax assets research and experimentation tax carryforwards subject to expiration.
Deferred Tax Assets Research And Experimentation Tax Carryforwards Subject To Expiration
Research and experimentation tax carryforwards
Finite Lived Intangible Assets By Major Class [Axis]
Finite-Lived Intangible Assets by Major Class
Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation By Asset Class [Domain]
Asset Class
Operating Income Loss
Loss from operations
Debt instrument, covenant description
Debt Instrument, Covenant Description
Advance deposits.
Advance Deposits
Advance deposits
Schedule Of Debt Instruments [Text Block]
Summary of Long-term Notes Payable
Long term debt maturities repayments of principal in year five and thereafter.
Long Term Debt Maturities Repayments Of Principal In Year Five And Thereafter
2026 and thereafter
Concentration Risk Type [Domain]
Concentration Risk Type
Entity Emerging Growth Company
Entity Emerging Growth Company
Preferred Stock [Text Block]
Convertible Preferred Stock
Income Tax Disclosure [Abstract]
Diagnostic tests.
Diagnostic Tests [Member]
Diagnostic Tests
Additional stock awards granted
Number of shares available for grant under all plans
Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
Debt instrument, covenant compliance
Debt Instrument, Covenant Compliance
Payments To Acquire Property Plant And Equipment
Purchase of property and equipment
Payments to Acquire Property, Plant, and Equipment, Total
Statement Geographical [Axis]
Geographical
Common stock, $0.001 par value, 200,000,000 authorized; 30,789,649 (2021) and 26,561,504 (2020) shares issued and outstanding
Common Stock Value
Common Stock, Value, Issued, Total
Common Stock, Value, Issued, Beginning Balance
Common Stock, Value, Issued, Ending Balance
Entity Address, State or Province
Entity Address State Or Province
Lease description
Lessor, Operating Lease, Lease Not yet Commenced, Description
Liabilities
Total liabilities
Disaggregation Of Revenue Table [Text Block]
Summary of Revenue
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
Risk‑free rate
Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Table]
Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Table]
Operating Leases Future Minimum Payments Due In Three Years
2024
Goodwill
Goodwill
Goodwill, Total
Goodwill, Beginning Balance
Goodwill, Ending Balance
Stockholders Equity Reverse Stock Split
Reverse stock split, description
Maturities Of Long Term Debt [Abstract]
Indefinite Lived Intangible Assets By Major Class [Axis]
Indefinite-lived Intangible Assets
Bdx004.
B D X004 [Member]
BDX004
Summary of Future Minimum Lease Payments Which Do Not Include Amounts for Common Area Maintenance, Insurance, or Taxes for Operating Lease Obligations
Schedule Of Future Minimum Rental Payments For Operating Leases Table [Text Block]
Class Of Stock [Domain]
Class of Stock
Operating Lease, Liability, Statement of Financial Position [Extensible Enumeration]
New Accounting Pronouncements And Changes In Accounting Principles [Text Block]
Recent Accounting Pronouncements
Notes Issued1
Convertible notes payable
Maximum percentage of common stock allowed to purchase by counterparty
Maximum Percentage of Common Stock Allowed to Purchase by Counterparty
Maximum percentage of common stock allowed to purchase by counterparty.
Other Payments To Acquire Businesses
Payments to acquire license rights
Other (expense) income:
Other Income And Expenses [Abstract]
Weighted-average shares outstanding used in computing net loss per share, basic and diluted
Weighted Average Number Of Share Outstanding Basic And Diluted
Weighted-average shares outstanding, basic and diluted
Percentage of conversion price per share of common stock.
Percentage Of Conversion Price Per Share Of Common Stock
Percentage of conversion price per share of common stock
Business Combinations [Abstract]
Prior to Second Anniversary
Debt Instrument Redemption Period Two [Member]
Second Tranche
Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
Change in contingent consideration
Net change to contingent consideration
Schedule Of Stockholders Equity Note Warrants Or Rights [Text Block]
Summary of Activity for Convertible Preferred Stock Warrants
Debt instrument maturity date extended.
Debt Instrument Maturity Date Extended
Extended debt instrument date
Business Acquisition [Line Items]
Business Acquisition [Line Items]
Defined Contribution Plan Employer Discretionary Contribution Amount
Defined contribution plan, employer discretionary contributions amount
Debt instrument prepayment penalty percentage.
Debt Instrument Prepayment Penalty Percentage
Debt instrument, prepayment penalty
Second Amendment
Second Amendment [Member]
Second amendment.
Reclassification of put option liability to additional paid in capital.
Reclassification Of Put Option Liability To Additional Paid In Capital
Reclassification of put option liability to additional paid-in capital
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
Weighted Average Contractual Life (Years), Exercisable - December 31, 2021
Restricted Cash
Restricted cash
Restricted Cash, Total
Series B Preferred Stock [Member]
Series B Preferred Stock
2027 and thereafter
Operating Leases Future Minimum Payments Due In Six Years And Thereafter
Operating leases future minimum payments due in six years and thereafter.
Accounts receivable, net of allowance for doubtful accounts of $158 and $180
Accounts Receivable Net Current
Accounts Receivable, after Allowance for Credit Loss, Current, Total
Debt Instrument Redemption Period [Domain]
Debt Instrument, Redemption, Period
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table]
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table]
Significant Accounting Policies [Text Block]
Summary of Significant Accounting Policies
Contract With Customer Liability Revenue Recognized
Revenue recognized
City Area Code
City Area Code
Schedule Of Share Based Payment Award Stock Options Valuation Assumptions Table [Text Block]
Summary of Weighted Average Assumptions
Other Current Assets [Member]
Other Current Assets
Deferred Tax Assets Gross
Total
Minimum annual volume percentage thereafter.
Minimum Annual Volume Percentage Thereafter
Minimum annual volume percentage thereafter
Equity Securities By Industry [Axis]
Industry Sector
Deferred Tax Assets Net
Total deferred tax assets after valuation allowance
Liabilities Noncurrent
Total non‑current liabilities
Goodwill And Intangible Assets Disclosure [Abstract]
Remaining estimated obligation.
Remaining Estimated Obligation
Remaining estimated obligation
Commitments And Contingencies
Commitments and contingencies
Class Of Warrant Or Right [Line Items]
Class Of Warrant Or Right [Line Items]
Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Text Block]
Schedule of Common Stock Equivalents Excluded from Diluted Net Loss Attributable to Common Stockholders
Lease agreement number of options to extend
Lease agreement number of options to extend
Percentage of royalty payments on net revenue.
Percentage Of Royalty Payments On Net Revenue
Percentage of royalty payments on net revenue
Schedule of depreciation and amortization expense related to property and equipment.
Schedule Of Depreciation And Amortization Expense Related To Property And Equipment Table [Text Block]
Schedule of Depreciation Expense Related to Property and Equipment
Finite Lived Intangible Assets Net
Intangible assets subject to amortization, Net Carrying Value
Finite-Lived Intangible Assets, Net, Beginning Balance
Finite-Lived Intangible Assets, Net, Ending Balance
Finite Lived Intangible Assets Amortization Expense Year Four
2025
Deferred Revenue [Domain]
Series A-2 preferred stock.
Series A2 Preferred Stock [Member]
Series A2 Preferred Stock
Issuance of common stock, shares
Stock Issued During Period Shares New Issues
Shares of common stock issued and sold
Scenario [Axis]
Business Combination Disclosure [Text Block]
Business Combinations
Summary of significant accounting policies.
Summary Of Significant Accounting Policies [Table]
Summary Of Significant Accounting Policies [Table]
Debt Instrument Redemption Period [Axis]
Debt Instrument, Redemption, Period
Sales Revenue Net [Member]
Revenue
Royalty Expense
Royalty expense
Contingent value rights.
Contingent Value Rights [Member]
Contingent Value Rights
Series F Preferred Stock [Member]
Series F Preferred Stock
Issuance of common stock under employee stock purchase plan, Shares
Stock Issued During Period, Shares, Employee Stock Purchase Plans
Earnings Per Share Basic And Diluted Other Disclosures [Abstract]
Liabilities Fair Value Disclosure
Total contingent consideration
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
Cash, cash equivalents, and restricted cash ‑ end of period
Cash, cash equivalents, and restricted cash ‑ beginning of period
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Total
Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right
Warrant issued to purchase shares
Warrant issued to purchase shares
Common Stock Purchase Agreement
Common Stock Purchase Agreement Member
Common stock purchase agreement member.
Revenue milestone
Revenue Milestone
Revenue milestone.
Percentage of royalty payments on net sales.
Percentage Of Royalty Payments On Net Sales
Percentage of royalty payments on net sales
Stock Issued During Period Value Conversion Of Convertible Securities
Conversion of preferred stock into common stock upon initial public offering
Unrecognized Tax Benefits Interest On Income Taxes Accrued
Accrued interest related to uncertain tax positions
Income Statement [Abstract]
Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]
Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets Noncurrent
Total non‑current assets
Net Cash Provided By Used In Investing Activities
Net cash and cash equivalents and restricted cash used in investing activities
Debt Disclosure [Text Block]
Debt
Capital Expenditures Incurred but Not yet Paid
Noncash purchases of property and equipment
Service-condition RSUs.
Service Condition R S Us [Member]
Service Condition R S Us
Proceeds from issuance of common stock under employee stock purchase plan
Proceeds From Issuance Of Common Stock Under Employee Stock Purchase Plan
Proceeds from issuance of common stock under employee stock purchase plan.
Share Based Compensation Arrangement By Share Based Payment Award Percentage Of Outstanding Stock Maximum
Percentage of number of shares of common stock issued and outstanding
Employee Related Liabilities Current
Compensation related accruals
Employee-related Liabilities, Current, Total
Property Plant And Equipment Net
Property and equipment, net
Total property and equipment, net
Property, Plant and Equipment, Net, Beginning Balance
Property, Plant and Equipment, Net, Ending Balance
Share based compensation arrangements by share based payment award non options reclassification of warrant liability to additional paid in capital weighted average exercise price.
Share Based Compensation Arrangements By Share Based Payment Award Non Options Reclassification Of Warrant Liability To Additional Paid In Capital Weighted Average Exercise Price
Weighted average exercise price, Reclassification of warrant liability to additional paid-in capital, warrants
Contract With Customer Liability Current
Deferred revenue
Common Stock Shares Issued
Common stock, issued
Common Stock, Shares, Issued, Total
Assets Noncurrent [Abstract]
Non‑current assets
Lease option to extend
Lessee, Operating Lease, Lease Not yet Commenced, Existence of Option to Extend [true false]
Deferred Income Tax Liabilities
Total deferred tax liabilities
Deferred Tax Liabilities, Gross, Total
Operating Lease, Right-of-Use Asset
Right of use assets
Lung diagnostic revenue.
Lung Diagnostic Revenue [Member]
Lung Diagnostic Revenue
Customer Concentration Risk [Member]
Customer Concentration Risk
Security Exchange Name
Security Exchange Name
Summary Of Significant Accounting Policies [Line Items].
Summary Of Significant Accounting Policies [Line Items]
Summary Of Significant Accounting Policies [Line Items]
Range [Member]
Statistical Measurement
Percentage of upper limit of employee salary to reduce forgiveness.
Percentage Of Upper Limit Of Employee Salary To Reduce Forgiveness
Percentage of upper limit of employee salary to reduce forgiveness
Long Term Debt Maturities Repayments Of Principal In Year Three
2024
Furniture and Fixtures
Furniture and Fixtures [Member]
Interest Expense [Member]
Interest Expense
Other Liabilities Noncurrent
Other long-term liabilities
Other Liabilities, Noncurrent, Total
Percentage of development and regulatory costs exercised using opt-out right.
Percentage Of Development And Regulatory Costs Exercised Using Opt Out Right
Percentage of development and regulatory costs exercised using opt-out right
Finite Lived Intangible Assets Gross
Intangible assets subject to amortization, Cost
Finite-Lived Intangible Assets, Gross, Total
Accrued legal contingency
Loss Contingency Accrual
Loss Contingency Accrual, Ending Balance
Loss Contingency Accrual, Beginning Balance
Subsequent Event Type [Domain]
Finite Lived Intangible Assets Net [Abstract]
Debt Disclosure [Abstract]
Document Period End Date
Document Period End Date
Series C Preferred Stock [Member]
Series C Preferred Stock
Year of ending royalty payments from first commercial sale.
Year Of Ending Royalty Payments From First Commercial Sale
Year of ending royalty payments from first commercial sale
Income Statement Location [Axis]
Income Statement Location
Investment Type Categorization [Member]
Investments
Accrued Liabilities Current
Accrued liabilities
Total accrued liabilities
Payments for proceeds from patent costs and intangible asset acquisition, net.
Payments For Proceeds From Patent Costs And Intangible Asset Acquisition Net
Patent costs and intangible asset acquisition, net
Series E convertible preferred stock warrants.
Series E Convertible Preferred Stock Warrants [Member]
Series E Convertible Preferred Stock Warrants
Warrant [Member]
Warrants
Loss Contingencies [Table]
Loss Contingencies [Table]
Common Stock Shares Authorized
Common stock, authorized
Common stock, shares authorized
Schedule Of Unrecognized Tax Benefits Roll Forward Table [Text Block]
Reconciliation of Unrecognized Tax Benefits
August two thousand and nineteen convertible notes.
August Two Thousand And Nineteen Convertible Notes [Member]
August 2019 Notes
Lease commencement date
Lease commencement Date
Percentage of license agreement and royalty payment related to acquired diagnostic test recognized revenue for non-screening tests
Percentage of revenue share payment related to acquired diagnostic test recognized revenue for non-screening tests.
Percentage Of Revenue Share Payment Related To Acquired Diagnostic Test Recognized Revenue For Non Screening Tests
Supplemental Cash Flow Information [Abstract]
Supplemental cash flow information
Statement Class Of Stock [Axis]
Class of Stock
Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities [Abstract]
Adjustments to reconcile net loss to net cash, cash equivalents, and restricted cash used in operating activities
Concentration Risk Benchmark [Domain]
Concentration Risk Benchmark
Shares issued or issuable, threshold limit description
Shares Issued or Issuable, Threshold Limit Description
Shares issued or issuable, threshold limit description.
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
Total
March two thousand and twenty convertible notes.
March Two Thousand And Twenty Convertible Notes [Member]
March 2020 Notes
Impairment Of Intangible Assets Excluding Goodwill
Impairment of intangible assets
Impairment of Intangible Assets (Excluding Goodwill), Total
Long Term Debt Maturities Repayments Of Principal In Year Two
2023
Debt Instrument [Table]
Debt Instrument [Table]
Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
Stock-based compensation
Debt instrument maturity date
Debt Instrument Maturity Date
Convertible notes, maturity date
Interest Paid Net
Cash paid for interest
Accounts Payable And Accrued Liabilities Disclosure [Text Block]
Accrued Liabilities
Effective Income Tax Rate Continuing Operations
Effective income tax rate
Deferred Tax Assets Net [Abstract]
Deferred Tax Assets:
Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
Unamortized debt discount and debt issuance costs
Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net, Total
Entity Address, Address Line Two
Entity Address Address Line2
Current Fiscal Year End Date
Current Fiscal Year End Date
Business Combination Contingent Consideration Liability Current
Current portion of contingent consideration
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
Net increase (decrease) in cash and cash equivalents and restricted cash
Portion at Fair Value Measurement [Member] [Default]
Portion at Fair Value Measurement [Member]
Fair value, measurement with unobservable inputs reconciliation reclassified to additional paid-in capital.
Fair Value Measurement With Unobservable Inputs Reconciliation Reclassified To Additional Paid In Capital
Reclassified to additional paid-in capital
Percentage of valuation allowance equal to net deferred tax assets.
Percentage Of Valuation Allowance Equal To Net Deferred Tax Assets
Percentage of valuation allowance equal to net deferred tax assets
Revenue share agreement.
Revenue Share Agreement [Member]
Revenue Share Agreement
Debt Conversion Converted Instrument Rate
Conversion rate
Revenue share expenses.
Revenue Share Expenses
Revenue share expenses
Bonus-to-options program.
Bonus To Options Program [Member]
Bonus-To-Options Program
Bio-rad license.
Bio Rad License [Member]
Bio-Rad License
Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
Outstanding - December 31, 2020, warrants
Outstanding - January 1, 2020, warrants
RSUs outstanding
Property Plant And Equipment [Member]
Property and Equipment
Disaggregation Of Revenue [Table]
Disaggregation Of Revenue [Table]
Notes Payable Current
Less: current maturities
Notes Payable, Current, Total
Write-off of debt issuance costs
Write off of Deferred Debt Issuance Cost
Debt instrument frequency of periodic payment
Debt Instrument Frequency Of Periodic Payment
Counterparty Name [Axis]
Counterparty Name
Assets [Abstract]
Assets
Landlord contribution towards cost of construction and tenant improvements
Landlord contribution towards cost of construction and tenant improvements
Basis of Presentation and Estimates.
Basis Of Presentation And Estimates Policy [Text Block]
Basis of Presentation and Estimates
Stock Issued During Period Shares Conversion Of Convertible Securities
Conversion of preferred stock into common stock upon initial public offering, shares
Debt instrument converted to common stock
LabCorp DD (formerly Covance)
LabCorp DD formerly Covance [Member]
LabCorp DD (formerly Covance).
Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities
Reductions related to settlements
Fair Value
Estimate of Fair Value Measurement [Member]
Accounts Payable Current
Accounts payable
Accounts Payable, Current, Total
Debt Instrument Name [Domain]
Debt Instrument, Name
Percentage for non-payroll costs.
Percentage For Non Payroll Costs
Percentage for non-payroll costs
Common Stock Par Or Stated Value Per Share
Common stock, par value
Common stock, par value
Revenue From Contract With Customer Policy [Text Block]
Deferred Revenue
Disclosure of accounting policy for initial public offering.
Initial Public Offering I P O Policy [Text Block]
Initial Public Offering ("IPO")
Effective Income Tax Rate Reconciliation Tax Credits Research
Research and developments credits
Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
Additions for tax positions related to the current year
Share based compensation arrangements by share based payment award non options grants in period weighted average exercise price.
Share Based Compensation Arrangements By Share Based Payment Award Non Options Grants In Period Weighted Average Exercise Price
Weighted average exercise price, Granted, warrants
Shares Outstanding
Common Stock Balance, Shares
Common Stock Balance, Shares
Ficlatuzumab.
Ficlatuzumab [Member]
Ficlatuzumab
COVID-19 diagnostic test revenue.
C O V I D19 Diagnostic Test Revenue [Member]
COVID-19 Test Revenue
Stockholders Equity Note [Abstract]
Value of put option recorded at issuance of convertible notes payable.
Value Of Put Option Recorded At Issuance Of Convertible Notes Payable
Value of put option recorded at issuance of convertible debt payable
Research And Development Expense Policy
Research and Development Expenses
Fair Value Liabilities Measured On Recurring Basis Unobservable Input Reconciliation By Liability Class [Domain]
Fair Value by Liability Class
Software and Software Development Costs [Member]
Software
Document Type
Document Type
Business Combination Consideration Transferred1
Total consideration amount
Business Combination, Consideration Transferred, Total
Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
Intangible assets
Preferred Stock Value
Preferred stock, $0.001 par value, 5,000,000 authorized; 0 (2021 and 2020) issued and outstanding
Preferred Stock, Value, Issued, Total
Preferred Stock, Value, Issued, Beginning Balance
Preferred Stock, Value, Issued, Ending Balance
Contingent Consideration Classified As Equity Fair Value Disclosure
Contingent consideration estimated fair value
Schedule Of Accrued Liabilities Table [Text Block]
Schedule of Accrued Liabilities
Assets Current
Total current assets
Number of cancer test.
Number Of Cancer Test
Number of blood based lung cancer test
Provision For Doubtful Accounts
Provision for doubtful accounts
Selling General And Administrative Expenses Policy [Text Block]
Sales, Marketing, General and Administrative Expenses
Fair Value By Liability Class [Axis]
Liability Class
Disaggregation Of Revenue [Line Items]
Disaggregation Of Revenue [Line Items]
Share Based Compensation Option And Incentive Plans Policy
Share-Based Compensation
Business combination contingent consideration arrangements common shares redemption amount.
Business Combination Contingent Consideration Arrangements Common Shares Redemption Amount
Contingent consideration arrangements, common shares, redemption amount
Contingent value rights shares.
Contingent Value Rights Shares
Contingent value rights shares
Series G convertible preferred stock warrants.
Series G Convertible Preferred Stock Warrants [Member]
Series G Convertible Preferred Stock Warrants
Longterm Debt Type [Domain]
Long-term Debt, Type
2006 Plan.
Two Thousand Six Plan [Member]
2006 Plan
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
Weighted Average Contractual Life (Years), Outstanding - January 1, 2021
Remaining life of outstanding performance condition options
Principal balance outstanding
Debt Instrument, Annual Principal Payment
Underwriting discounts and commissions and offering expenses payable
Underwriting Discounts And Commissions And Offering Expenses Payable
Underwriting discounts and commissions and offering expenses payable.
Income Tax Expense Benefit
Provision for income taxes
Income Tax Expense (Benefit), Total
Other Assets Current
Other current assets
Earnings Per Share Basic And Diluted
Net loss per share, basic and diluted
Earnings Per Share, Basic and Diluted, Total
Debt instrument, percentage of stated interest rate added to principal value of notes payable.
Debt Instrument Percentage Of Stated Interest Rate Added To Principal Value Of Notes Payable
Percentage of interest rate added to principal value of notes payable
Leases [Abstract]
Disclosure of accounting policy for contingent consideration.
Contingent Consideration Policy [Text Block]
Contingent Consideration
Antidilutive Securities Excluded From Computation Of Earnings Per Share By Antidilutive Securities [Axis]
Antidilutive Securities
Loss Contingencies [Line Items]
Loss Contingencies [Line Items]
Measurement Basis [Axis]
Share based compensation arrangement by share based payment award options granted weighted average remaining contractual term1.
Sharebased Compensation Arrangement By Sharebased Payment Award Options Granted Weighted Average Remaining Contractual Term1
Weighted Average Contractual Life (Years), Granted
Put option liability.
Put Option Liability [Member]
Put Option Liability
Increase to put option liability.
Increase To Put Option Liability
Increase to put option liability
Deferred Tax Assets Operating Loss Carryforwards
Net operating loss carryforwards
Deferred Tax Assets, Operating Loss Carryforwards, Total
Common Stock Shares Outstanding
Common stock, outstanding
Common Stock, Shares, Outstanding, Beginning Balance
Common Stock, Shares, Outstanding, Ending Balance
Class Of Warrant Or Right [Domain]
Class of Warrant or Right
Plan Name [Axis]
Plan Name
Finite Lived Intangible Assets [Line Items]
Finite Lived Intangible Assets [Line Items]
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
Less accumulated depreciation
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Total
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Beginning Balance
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Ending Balance
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
Options forfeited
Revenue Recognition Policy [Text Block]
Revenue Recognition
Payments To Acquire Businesses Net Of Cash Acquired
Contingent consideration cash payment
Payments to Acquire Businesses, Net of Cash Acquired, Total
Restricted cash collateral account
Cash Collateral for Borrowed Securities
Operating Expenses
Total operating expenses
Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures
Forfeited/canceled, warrants
PPP loan.
P P P Loan [Member]
PPP Loan
I P O [Member]
Initial Public Offering
IPO
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
Weighted Average Exercise Price, Outstanding - December 31, 2021
Weighted Average Exercise Price, Outstanding - January 1, 2021
Net Cash Provided By Used In Operating Activities [Abstract]
Cash flows from operating activities
Collateral Held [Axis]
Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
Warrant, exercise price
Earnings Per Share [Abstract]
Denominator
Increase Decrease In Other Current Assets
Other current assets
Net loss
Net Income Loss
Net loss
Net loss attributable to common stockholders
Concentration Risk [Line Items]
Concentration Risk [Line Items]
Schedule Of Effective Income Tax Rate Reconciliation Table [Text Block]
Schedule of Effective Income Tax Rate Reconciliation
Partial repayments of debt
Partial repayments of debt.
Concentration Risk Credit Risk
Concentrations of Credit Risk and Other Uncertainties
Finite Lived Intangible Asset Useful Life
Finite-lived intangible asset, useful life
Research And Development Expense [Member]
Research and Development
Document Fiscal Period Focus
Document Fiscal Period Focus
Proceeds From Payments For Other Financing Activities
Other
Interest Bearing Deposits [Member]
Interest-bearing Deposits
Income Tax Examination Description
Income tax examination details
Accounting Policies [Abstract]
Share based compensation arrangement by share based payment award non options outstanding weighted average exercise price.
Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding Weighted Average Exercise Price
Weighted average exercise price,Outstanding - December, 31, 2020, warrants
Weighted average exercise price, Outstanding - January 1, 2020, warrants
Valuation Allowance Deferred Tax Asset Explanation Of Change
Valuation allowance, deferred tax asset, explanation of change
Entity Address, Address Line One
Entity Address Address Line1
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
Stock Options, Outstanding - December 31, 2021
Stock Options, Outstanding - January 1, 2021
Number of outstanding stock options granted
Number of outstanding stock options granted
Series H Preferred Stock [Member]
Series H Convertible Preferred Stock
Final settlement payment to third parties
Litigation Settlement, Amount Awarded to Other Party
Business acquisition contingent consideration number of installments.
Business Acquisition Contingent Consideration Number Of Installments
Contingent consideration number of installments
Liabilities Current
Total current liabilities
Finite Lived Intangible Assets Accumulated Amortization
Intangible assets subject to amortization, Accumulated Amortization
Profit Loss
Net loss
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Total
Number of commercial blood based test.
Number Of Commercial Blood Based Test
Number of commercial blood-based test
Entity Address, Postal Zip Code
Entity Address Postal Zip Code
Aggregate Intrinsic Value, Outstanding - December 31, 2021
Aggregate Intrinsic Value, Outstanding - January 1, 2021
Aggregate Intrinsic Value, Outstanding - December 31, 2021
Aggregate Intrinsic Value, Outstanding - January 1, 2021
Intrinsic value
Leased property building capacity
Leased property building capacity.
Debt Instrument Convertible Remaining Discount Amortization Period1
Early amortization of loan payment schedule
Subsequent Event [Table]
Current portion of notes payable
Convertible Notes Payable, Current
Products And Services [Domain]
Product and Service
Deferred revenue.
Deferred Revenue [Member]
Deferred Revenue
Temporary Equity Carrying Amount Attributable To Parent
Temporary Equity Balance
Temporary Equity Balance
Reclassification of warrant liability to additional paid-in-capital.
Reclassification Of Warrant Liability To Additional Paid In Capital
Reclassification of warrant liability to additional paid-in capital
At-The-Market Offering
At The Market Offering [Member]
At The Market Offering [Member]
Revenues
Revenues
Revenues
Revenues, Total
Proceeds From Issuance Initial Public Offering
Proceeds from initial public offering
Class Of Stock Disclosures [Abstract]
Equipment [Member]
Lab Equipment
Convertible Preferred Stock [Member]
Convertible Preferred Stock
Arrangements And Nonarrangement Transactions [Member]
Collaborative Arrangement and Arrangement Other than Collaborative
Net Cash Provided By Used In Operating Activities
Net cash and cash equivalents and restricted cash used in operating activities
Business combination contingent consideration final payment.
Business Combination Contingent Consideration Final Payment
Business combination contingent consideration final payment
Increase Decrease In Other Noncurrent Assets And Liabilities Net
Other long-term assets and liabilities
Two thousand twenty one term loan.
Two Thousand Twenty One Term Loan [Member]
2021 Term Loan
Statement Equity Components [Axis]
Equity Components
Proceeds from issuance of term loan and notes payable.
Proceeds From Issuance Of Term Loan And Notes Payable
Proceeds from term loan and notes payable
Assets Current [Abstract]
Current assets
Other member.
Other [Member]
Other
Tax Credit Carryforward Description
Description of tax credit carryforward expiration
Entity Registrant Name
Entity Registrant Name
Convertible preferred stock and convertible notes payable converted to common stock.
Convertible Preferred Stock And Convertible Notes Payable Converted To Common Stock
Convertible preferred stock and convertible notes payable converted into shares of common stock
Accounting Changes and Error Corrections [Abstract]
Disclosure of accounting policy for reverse stock split.
Reverse Stock Split Policy [Text Block]
Reverse Stock Split
Business acquisition contingent consideration gross margin target period.
Business Acquisition Contingent Consideration Gross Margin Target Period
Business acquisition contingent consideration gross margin target period
Stockholders Equity Note Disclosure [Text Block]
Equity
Upper limit of employee salary to reduce forgiveness.
Upper Limit Of Employee Salary To Reduce Forgiveness
Upper limit of employee salary to reduce forgiveness
Entity Interactive Data Current
Entity Interactive Data Current
Entity Address, City or Town
Entity Address City Or Town
Major Customers [Axis]
Customer
Indefinite Lived Intangible Assets Major Class Name [Domain]
Indefinite-lived Intangible Assets, Major Class Name
Accounts Receivable [Member]
Accounts Receivable
Fair value measurement with unobservable inputs interest expense.
Fair Value Measurement With Unobservable Inputs Interest Expense
Interest expense
Accrued interest, amortization of debt issuance costs and other
Accrued Interest Amortization Of Debt Issuance Costs And Other
Accrued interest, amortization of debt issuance costs and other.
Capital Units Deductions From Total Cost To Investors
Discounts and commission
Current portion of contingent consideration.
Current Portion Of Contingent Consideration [Member]
Current Portion of Contingent Consideration
Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
Expected term (in years)
Trading Symbol
Trading Symbol
Shares issued as commitment fee, value
Shares Issued as Commitment Fee, Value
Shares issued as commitment fee, value.
Net Cash Provided By Used In Investing Activities [Abstract]
Cash flows from investing activities
Concentration Risk By Type [Axis]
Concentration Risk Type
Disclosure of information about liabilities measured at fair value on recurring basis.
Fair Value Liabilities Measured On Recurring Basis [Table]
Fair Value Liabilities Measured On Recurring Basis [Table]
Local Phone Number
Local Phone Number
Stockholders Equity
Balances
Balances
Total stockholders' equity
Payments Of Debt Issuance Costs
Payment of debt issuance costs
Subsequent Event Type [Axis]
Number of preferred stock converted into common stock.
Number Of Preferred Stock Converted Into Common Stock
Number of preferred stock converted into common stock
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
Fair Value Liabilities Measured On Recurring Basis [Line Items]
Fair Value Liabilities Measured On Recurring Basis [Line Items]
Unrecognized Tax Benefits
Balance at December 31
Balance at January 1
Performance condition options.
Performance Condition Options [Member]
Performance Condition Options
Notes payable 2018 notes.
Notes Payable2018 Notes [Member]
2018 Notes
Preferred Stock Shares Issued
Preferred stock, issued
Preferred stock, issued
Preferred Stock, Shares Issued, Total
Repayments Of Long Term Debt
Repayment of term loan and notes payable
Repayments of Long-term Debt, Total
Series E Preferred Stock [Member]
Series E Preferred Stock
Range [Axis]
Statistical Measurement
Entity Small Business
Entity Small Business
Direct costs and expenses.
Direct Costs And Expenses
Direct costs and expenses
Preferred Stock Shares Outstanding
Preferred stock, outstanding
Preferred Stock, Shares Outstanding, Beginning Balance
Preferred Stock, Shares Outstanding, Ending Balance
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
Stock Options, Forfeited/canceled
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Total
Fair Value Measurements Fair Value Hierarchy [Domain]
Fair Value Hierarchy and NAV
Other Inventory Supplies
Inventory
Short Term Debt Type [Domain]
Short-term Debt, Type
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
Stock‑based compensation
APIC, Share-based Payment Arrangement, Increase for Cost Recognition, Total
Credit Facility [Axis]
Schedule Of Deferred Tax Assets And Liabilities Table [Text Block]
Schedule of Deferred Tax Assets and Liabilities
Percentage of fee payments on net sales.
Percentage Of Fee Payments On Net Sales
Percentage of fee payments on net sales
Common Stock Voting Rights
Common stock, voting rights
Property Plant And Equipment Useful Life
Property, plant and equipment, useful Lives
CARES act.
C A R E S Act [Member]
CARES Act
Operating Leases Future Minimum Payments Due
Total
Business Acquisition [Axis]
Business Acquisition
Segment Reporting [Abstract]
Balance Sheet Location [Axis]
Balance Sheet Location
Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period
Number of common stock may be issued under incentive plan
Fair Value Measurement Policy Policy [Text Block]
Fair Value of Financial Instruments
Percentage of license income generated from licensing.
Percentage Of License Income Generated From Licensing
Percentage of license income generated from licensing
Fair Value Adjustment Of Warrants
Change in fair value of warrant liability
Increase in value of the warrant liability
Change in fair value of warrant liability
Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted
Granted, warrants
Additional Paid In Capital
Additional paid‑in capital
Additional Paid in Capital, Total
Additional Paid in Capital, Beginning Balance
Additional Paid in Capital, Ending Balance
Reconciliation Of Unrecognized Tax Benefits Excluding Amounts Pertaining To Examined Tax Returns Roll Forward
Defined Contribution Plan [Text Block]
Defined Contribution 401(k) Plan
Disclosure of accounting policy for warrant liability.
Warrant Liability Policy [Text Block]
Warrant Liability
Indefinite lived intangible assets excluding goodwill gross.
Indefinite Lived Intangible Assets Excluding Goodwill Gross
Intangible assets not subject to amortization, Cost
Change in fair value of contingent consideration excluding accretion expense.
Change In Fair Value Of Contingent Consideration Excluding Accretion Expense
Change in fair value of contingent consideration
Percentage of development and regulatory costs.
Percentage Of Development And Regulatory Costs
Responsible percentage of development and regulatory costs
Net Income Loss [Abstract]
Numerator
Options and restricted stock units.
Options And Restricted Stock Units [Member]
Options and Restricted Stock Units
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
Exercise price
Weighted Average Exercise Price, Granted
Debt instrument, percentage of stated interest rate, paid in cash.
Debt Instrument Percentage Of Stated Interest Rate Paid In Cash
Percentage of interest rate, paid in cash
Sale Of Stock Name Of Transaction [Domain]
Sale of Stock
Organization and description of business.
Organization And Description Of Business [Line Items]
Organization And Description Of Business [Line Items]
Contract with customer liability reclassified from non-current liabilities.
Contract With Customer Liability Reclassified From Non Current Liabilities
Amount reclassified from non-current liabilities
Temporary Equity Shares Issued
Convertible preferred stock, issued
Description of offering period under plan.
Description Of Offering Period Under Plan
Description of offering period under plan
Loss
Loss [Member]
Loss member.
Revenue From Contract With Customer [Abstract]
Percentage of fully diluted equity for bonus awarded.
Percentage Of Fully Diluted Equity For Bonus Awarded
Percentage of fully diluted equity for bonus awarded
Plan Name [Domain]
Plan Name
Contingent Consideration Type [Domain]
Operating Leases Future Minimum Payments Due Current
2022
Class Of Stock [Line Items]
Class Of Stock [Line Items]
Components Of Deferred Tax Assets [Abstract]
Number of SARS-CoV-2 test.
Number Of S A R S Co V2 Test
Number of SARS-CoV-2 test
Goodwill And Intangible Assets Goodwill Policy
Goodwill
Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
2022
Depreciation
Depreciation expense
Depreciation, Total
Valuation Allowance Deferred Tax Asset Change In Amount
Increase in valuation allowance
Base rent per month from commencement date
Base rent per month from commencement date.
Effective Income Tax Rate Reconciliation State And Local Income Taxes
State income taxes, net of federal benefit
Amortization Of Intangible Assets
Amortization expense related to definite-lived intangible assets
Amortization of Intangible Assets, Total
Issuance of common stock
Stock Issued During Period Value New Issues
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]
Contingent consideration.
Contingent Consideration [Member]
Contingent Consideration
Fair Value Liabilities Measured On Recurring Basis [Text Block]
Schedule of Reported Fair values of Contingent Consideration
Poc clinical trials.
P O C Clinical Trials [Member]
POC Clinical Trials
Interest Expense
Interest expense
Interest Expense, Total
Operating Expense [Member]
Operating Expense
Indefinite Lived Intangible Assets Excluding Goodwill
Intangible assets not subject to amortization, Net Carrying Value
Indefinite-lived Intangible Assets (Excluding Goodwill), Total
Indefinite-lived Intangible Assets (Excluding Goodwill), Beginning Balance
Indefinite-lived Intangible Assets (Excluding Goodwill), Ending Balance
Cash Acquired From Acquisition
Business acquisition contingent consideration gross margin target
Series A-3 preferred stock.
Series A3 Preferred Stock [Member]
Series A3 Preferred Stock
Warrant liability.
Warrant Liability [Member]
Warrant Liability
Notes Payable
Notes payable, total
Share Based Compensation
Stock‑based compensation expense
Share-based Payment Arrangement, Noncash Expense, Total
Schedule Of Share Based Compensation Stock Options Activity Table [Text Block]
Summary of Stock Option Activity
Payroll costs excludes compensation of an employee.
Payroll Costs Excludes Compensation Of Employee
Payroll costs excludes compensation of an employee
Long-Lived Tangible Asset [Domain]
Debt Instrument Carrying Amount
Loan principle amount
Notes/Loan payable
2016 Plan.
Two Thousand And Sixteen Plan [Member]
2016 Plan
Business Acquisition Description Of Acquired Entity
Business acquisition description
Class Of Warrant Or Righst Date From Which Warrants Or Rights Exercisable
Warrants expiration date
Business Combination Contingent Consideration Liability Noncurrent
Contingent consideration
Warrants for convertible preferred stock.
Warrants For Convertible Preferred Stock [Text Block]
Warrants to Purchase Convertible Preferred Stock
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
Stock Options, Exercisable - December 31, 2021
Long-term notes payable
Long-term notes payable, net of current portion
Long-term notes payable
Long Term Notes Payable
Net Cash Provided By Used In Financing Activities
Net cash and cash equivalents and restricted cash provided by financing activities
Share Based Compensation Arrangement By Share Based Payment Award Maximum Employee Subscription Rate
Percentage of earnings used for purchase of common stock
Commitments And Contingencies Disclosure [Abstract]
Assets
Total assets
Contingent value rights percentage.
Contingent Value Rights Percentage
Contingent value rights percentage
Service [Member]
Services
Description of voting power or value of stock for employee participation in offering period.
Description Of Voting Power Or Value Of Stock For Employee Participation In Offering Period
Description of voting power or value of stock for employee participation in offering period
Fair Value Inputs Level2 [Member]
Level 2
Percentage of royalty payments not required to pay on net revenue.
Percentage Of Royalty Payments Not Required To Pay On Net Revenue
Percentage of royalty payments not required on net revenue
Allowance For Doubtful Accounts Receivable
Allowance for doubtful accounts receivable
Accounts Receivable, Allowance for Credit Loss, Beginning Balance
Accounts Receivable, Allowance for Credit Loss, Ending Balance
Exercise of stock options, shares
Stock Issued During Period Shares Stock Options Exercised
Common stock issued upon exercise of stock options, shares
Stock Options, Exercised
Finite Lived Intangible Assets Amortization Expense Table [Text Block]
Schedule of Amortization Expense Related to Definite-Lived Intangible Assets
Statement [Line Items]
Statement [Line Items]
Total liabilities and stockholders' equity
Liabilities And Stockholders Equity
Finite Lived Intangible Assets Amortization Expense Year Two
2023
Balance Sheet Location [Domain]
Balance Sheet Location
Stock issuable per day, number of shares
Sale of Stock, Stock Issuable Per Day, Shares
Sale of stock, stock issuable per day, shares.
Class Of Warrant Or Right [Axis]
Class of Warrant or Right
Property Plant And Equipment [Abstract]
Statement Of Cash Flows [Abstract]
Additional Paid In Capital [Member]
Additional Paid-in Capital
Title of 12(b) Security
Security12b Title
Federal net operating loss carryforwards
Deferred Tax Assets Operating Loss Carryforwards Subject To Expiration
Net proceeds percentage of cash payment to the cvr holders.
Net Proceeds Percentage Of Cash Payment To C V R Holders
Net proceeds percentage of cash payment to the CVR holders
Letter of credit subject to contingent reduction over the term of the lease
Long-term Line of Credit
Long-term Line of Credit, Total
Fair Value Inputs Level3 [Member]
Level 3
Debt Instrument [Line Items]
Debt Instrument [Line Items]
Entity Well Known Seasoned Issuer
Entity Well Known Seasoned Issuer
Debt Instrument Convertible Conversion Price1
Conversion price
Centennial Valley Properties I, LLC Lease Agreement
Centennial Valley Properties I, LLC Lease Agreement.
Share Based Compensation Arrangements By Share Based Payment Award Award Type And Plan Name [Domain]
Award Type
Minimum liquidity ratio covenant
Minimum Liquidity Ratio Covenant
Minimum liquidity ratio covenant.
At-the-Money Offering
At-the-Money Offering [Policy Text Block]
At the money offering policy text block.
Fair Value By Fair Value Hierarchy Level [Axis]
Fair Value Hierarchy and NAV
Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period
Option expiration period
Share Based Compensation Arrangement By Share Based Payment Award Discount From Market Price Offering Date
Percentage of fair market value of common stock for purchase under plan
Increase Decrease In Accounts Payable And Accrued Liabilities
Accounts payable and other accrued liabilities
Increase (Decrease) in Accounts Payable and Accrued Liabilities, Total
Property Plant And Equipment [Text Block]
Schedule of Property and Equipment
Schedule Of Maturities Of Long Term Debt Table [Text Block]
Scheduled Principal Repayments (Maturities) of Long-term Obligations
Capital Units Total Cost To Investors
Direct offering costs
Term of royalty payments from first commercial sale.
Term Of Royalty Payments From First Commercial Sale
Term of royalty payments from first commercial sale
Debt Instrument Interest Rate Stated Percentage
Interest rate
Deferred Tax Assets Liabilities Net
Net deferred tax assets and liabilities
2020 equity incentive plan.
Two Thousand Twenty Equity Incentive Plan [Member]
2020 Equity Incentive Plan
Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
Change in valuation allowance
Fair Value, by Balance Sheet Grouping [Table]
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
Stock Options, Granted
Number of performance-condition options granted
Entity Current Reporting Status
Entity Current Reporting Status
Centura Healthcare.
Centura Healthcare [Member]
Centura Healthcare
Revenue From Contract With Customer [Text Block]
Revenue and Accounts Receivable Credit Concentration
Investment Type [Axis]
Investment Type
Entity Voluntary Filers
Entity Voluntary Filers
Scenario [Domain]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Documents Incorporated by Reference
Documents Incorporated By Reference [Text Block]
Rent after fixed escalation provisions
Rent after fixed escalation provisions.
Warrants And Rights Outstanding Maturity Date
Warrants, expires period
Put Option Liability
Disclosure of accounting policy for put-option liability
Put Option Liability Policy [Text Block]
Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
Reductions related to a lapse of statute
Earnings Per Share Policy [Text Block]
Net Loss per Common Share
Accounts Payable [Member]
Accounts Payable
Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Text Block]
Summary of Pre-tax Share-based Compensation Expense
Notes Payable To Bank Current
Current portion of notes payable
Schedule of Earnings Per Share, Basic, by Common Class, Including Two Class Method [Table]
Compensation And Retirement Disclosure [Abstract]
Computer Equipment
Computer Equipment [Member]
Operating Leases Future Minimum Payments Due In Two Years
2023
Lease renewal term
Lessee, Operating Lease, Lease Not yet Commenced, Renewal Term
Selling General And Administrative Expenses [Member]
Selling, Marketing, General and Administrative
Sales, Marketing, General and Administrative
Auditor Firm ID
Longterm Debt Type [Axis]
Long-term Debt, Type
Other Noncurrent Liabilities [Member]
Other Long-term Liabilities
Percentage of probabilities of contingent consideration successful achievement milestone discount rates range.
Percentage Of Probabilities Of Contingent Consideration Successful Achievement Milestone Discount Rates Range
Percentage of probabilities of contingent consideration successful achievement of specified product gross margin targets discount rates range
After Second Anniversary, Prior to October 19, 2025
Debt Instrument, Redemption, Period Three [Member]
Contingent value rights.
Contingent Value Rights
Contingent value rights
Income Statement Location [Domain]
Income Statement Location
Interest expense limitation
Deferred Tax Asset, Interest Carryforward
Fair Value Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Text Block]
Schedule of Changes in Contingent Consideration and Financial Liabilities
U S
United States
Receivables Trade And Other Accounts Receivable Allowance For Doubtful Accounts Policy
Accounts Receivable and Allowance for Doubtful Accounts
Class Of Warrant Or Right [Table]
Class Of Warrant Or Right [Table]
Auditor Name
Carrying Value
Reported Value Measurement [Member]
Milestone payment
Milestone payment.
Options to purchase common stock.
Options To Purchase Common Stock [Member]
Options to Purchase Common Stock
Organization and description of business.
Organization And Description Of Business [Abstract]
Preferred Stock Shares Authorized
Preferred stock, authorized
Preferred stock, shares authorized
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
Weighted Average Exercise Price, Exercisable - December 31, 2021
At-the-Money Offering
At-the-Money Offering [Member]
At-the-Money Offering [Member]
Cash Collateralized
Cash collateralized.
Minimum [Member]
Minimum
Minimum
Fair Value Measurement Frequency [Domain]
Measurement Frequency
Expense Related To Distribution Or Servicing And Underwriting Fees
Underwriting discounts and commissions
Exercise of stock options
Stock Issued During Period Value Stock Options Exercised
Common stock issued upon exercise of stock options
Payments To Acquire Businesses Gross
Cash
Lincoln Park
Lincoln Park Member
Lincoln Park.
CellCarta License.
Cell Carta License [Member]
CellCarta License
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
Number of RSUs granted
Finite Lived Intangible Assets Amortization Expense Next Twelve Months
2022
Fair value of warrants issued
Warrants Not Settleable In Cash Fair Value Disclosure
Estimated air value of warrants issued
Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
Warrants to purchase shares of common stock
Warrant issued to purchase shares
Organization Consolidation And Presentation Of Financial Statements Disclosure [Text Block]
Organization and Description of Business
The Big Ten Conference.
The Big Ten Conference [Member]
The Big Ten Conference
Schedule Of Business Acquisitions By Acquisition [Table]
Schedule Of Business Acquisitions By Acquisition [Table]
Document Annual Report
Document Annual Report
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions And Methodology [Abstract]
Deferred Tax Assets Valuation Allowance
Valuation allowance
Deferred Tax Assets, Valuation Allowance, Total
Intangible Assets Net Excluding Goodwill
Intangible assets, net
Intangible assets, Net Carrying Value
Net Cash Provided By Used In Financing Activities [Abstract]
Cash flows from financing activities
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
Unrecognized remaining stock based compensation balance
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount, Total
Product life and patent life.
Product Life And Patent Life [Member]
Product Life and Patent Life
Debt Instrument [Axis]
Debt Instrument
Goodwill Impairment Loss
Goodwill impairments loss
Entity Filer Category
Entity Filer Category
Document Fiscal Year Focus
Document Fiscal Year Focus
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table]
Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table]
Convertible Debt Securities [Member]
Convertible Debt
Scheduleof Finite Lived Intangible Assets Future Amortization Expense Table [Text Block]
Schedule of Future Estimated Amortization Expense of Intangible Assets
Period of escalations of sales.
Period Of Escalations Of Sales
Period of escalations of sales
Construction in Process
Construction in Progress [Member]
Effective income tax rate reconciliation permanent items.
Effective Income Tax Rate Reconciliation Permanent Items
Permanent items
Permanent items
Retained Earnings Accumulated Deficit
Accumulated deficit
Retained Earnings (Accumulated Deficit), Total
Retained Earnings (Accumulated Deficit), Beginning Balance
Retained Earnings (Accumulated Deficit), Ending Balance
Payments to acquire Oncimmune.
Payments To Acquire Oncimmune
Payments to acquire Oncimmune assets
Income Tax Disclosure [Text Block]
Income Taxes
Depreciation And Amortization
Depreciation and amortization
Depreciation, Depletion and Amortization, Nonproduction, Total
Series B-1 Convertible Preferred Stock.
Series B1 Convertible Preferred Stock [Member]
Series B1 Convertible Preferred Stock
Net proceeds from sale of common shares after deducting underwriting discounts and commissions and offering expenses
Proceeds From Issuance Of Common Stock Net
Proceeds from issuance of common stock net.
License agreement expiry date.
License Agreement Expiry Date
License expiry date
Entity Ex Transition Period
Entity Ex Transition Period
Fair Value Disclosures [Abstract]
Property Plant And Equipment Disclosure [Text Block]
Property and Equipment
Proceeds From Convertible Debt
Proceeds from issuances of convertible notes payable
Series G Preferred Stock [Member]
Series G Preferred Stock
Maximum [Member]
Maximum
Maximum
Janssen Research and Development, LLC.
Janssen Research And Development L L C [Member]
Janssen Research and Development, LLC
Entity Central Index Key
Entity Central Index Key
Cash And Cash Equivalents Restricted Cash And Cash Equivalents Policy
Restricted Cash
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
Options vested
Business Acquisition Acquiree [Domain]
Business Acquisition, Acquiree
2026
Long-Term Debt, Maturity, Year Five
Debt instrument interest added to principal value.
Debt Instrument Interest Added To Principal Value
Interest added to principal value
Payables And Accruals [Abstract]
Debt instrument description
Debt Instrument Description
Loan description
Cash And Cash Equivalents Policy [Text Block]
Cash and Cash Equivalents
Entity Tax Identification Number
Entity Tax Identification Number
Debt Instruments [Abstract]
Equity Component [Domain]
Equity Component
Preferred Stock Par Or Stated Value Per Share
Preferred stock, par value
Preferred stock, par value
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
Expected volatility
Gain on debt extinguishments, net
Gain on debt extinguishments, net
Gain (loss) on debt extinguishment
Gains Losses On Extinguishment Of Debt
Gain (Loss) on Extinguishment of Debt, Total
Organization and description of business.
Organization And Description Of Business [Table]
Organization And Description Of Business [Table]
Property Plant And Equipment Policy [Text Block]
Property and Equipment
Stockholders Equity Note Stock Split Conversion Ratio1
Reverse stock split ratio
New Accounting Pronouncements And Changes In Accounting Principles [Abstract]
2027 and thereafter
Finite Lived Intangible Assets Amortization Expense Year Six And Thereafter
Finite lived intangible assets amortization expense year six and thereafter.
Finite Lived Intangible Assets Future Amortization Expense [Abstract]
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
Amortization period
Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
Accruals and reserves
Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Total
Debt instrument additional interest expense fee percentage.
Debt Instrument Additional Interest Expense Fee Percentage
Debt instrument, additional interest expense fee
Repurchase.
Repurchase [Member]
Repurchase
Extra allowance amount per rentable square feet
Additional tenant improvement allowance per rentable square feet
Deferred Tax Liabilities [Abstract]
Deferred Tax Liabilities:
Adjustments To Additional Paid In Capital Warrant Issued
Reclassification of preferred stock warrant liability and put option into additional paid-in capital upon initial public offering
Share based compensation arrangement by share based payment award non-options forfeitures and expirations in period weighted average exercise price.
Share Based Compensation Arrangement By Share Based Payment Award Non Options Forfeitures And Expirations In Period Weighted Average Exercise Price
Weighted average exercise price, Forfeited/canceled, warrants
Accounts receivable
Increase Decrease In Accounts Receivable
Subsequent Events [Abstract]
Subsequent Event [Line Items]
Leasehold Improvements [Member]
Leasehold Improvements
Concentration Risk Percentage1
Concentration risk, percentage
License [Member]
License Rights
Amount of accumulated amortization of intangible assets, excluding goodwill.
Intangible Assets Accumulated Amortization Excluding Goodwill
Intangible assets, Accumulated Amortization
Number of shares issued during the period as a result of the conversion of convertible securities classified as common stock.
Stock Issued During Period Shares Conversion Of Convertible Securities Common Stock
Conversion of convertible debt into common stock upon initial public offering, shares
Statement [Table]
Statement [Table]
Interest rate on extra allowance amount
Interest rate on extra allowance amount
Selling General And Administrative Expense
Sales, marketing, general and administrative
Selling, General and Administrative Expense, Total
Entity File Number
Entity File Number
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Direct costs and expenses policy.
Direct Costs And Expenses Policy [Text Block]
Direct Costs and Expenses
Retained Earnings [Member]
Accumulated Deficit
Shares Issued Price Per Share
Common stock price per share
Inventory Supplies Policy
Inventory
Number of equal annual installments for award vesting.
Number Of Equal Annual Installments For Award Vesting
Number of equal annual installments for award vesting
Payments Of Stock Issuance Costs
Equity financing costs
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Debt Instrument Fee Amount
Facility fee amount
Liabilities Current [Abstract]
Current liabilities
Equity Securities Industry [Member]
Industry Sector
Disclosure Of Compensation Related Costs Share Based Payments [Text Block]
Share Based Compensation
Shares Committed Under ESPP
Shares Committed Under E S P P [Member]
Shares committed under ESPP.
Subsequent Event
Subsequent Event [Member]
Schedule Of Intangible Assets And Goodwill Table [Text Block]
Schedule of Intangible Assets, Excluding Goodwill
Commitments And Contingencies Disclosure [Text Block]
Commitments and Contingencies
Operating Lease, Liability, Total
Operating Lease, Liability
Lease liabilities
Finite Lived Intangible Assets Amortization Expense Year Three
2024
Common Stock [Member]
Common Stock
Property Plant And Equipment Gross
Property and equipment, gross
Property, Plant and Equipment, Gross, Total
Property, Plant and Equipment, Gross, Beginning Balance
Property, Plant and Equipment, Gross, Ending Balance
Goodwill And Intangible Assets Disclosure [Text Block]
Goodwill and Intangible Assets
Entity Public Float
Entity Public Float
Long Term Debt Fair Value
Borrowings
Cover [Abstract]
Credit Facility [Domain]
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
Weighted average grant date fair value
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value, Beginning Balance
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value, Ending Balance
Fair Value By Asset Class [Axis]
Asset Class
Deferred Tax Assets Tax Credit Carryforwards Research
Research and development tax credits
Temporary Equity Shares Outstanding
Temporary Equity Balance, Shares
Temporary Equity Balance, Shares
Convertible preferred stock, outstanding
Fair Value Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Table]
Fair Value Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Table]
Statement Of Stockholders Equity [Abstract]
Schedule Of Property Plant And Equipment [Table]
Schedule Of Property Plant And Equipment [Table]
Concentration Risk [Table]
Concentration Risk [Table]
Number Of Operating Segments
Number of operating segments
Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
Ending balances
Beginning balances
Litigation Claims and Assessments
Litigation Claims And Assessments [Member]
Litigation claims and assessments.
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]
Fair Value Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Fair Value Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Thereafter
Debt Instrument, Redemption, Period Four [Member]
Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]
Restricted Stock Units R S U [Member]
Restricted Stock Units (RSUs)
Restricted Stock Units
Non-cash debt issuance costs included in Accrued liabilities
Debt Issuance Costs Incurred During Noncash or Partial Noncash Transaction
Direct offering expenses.
Direct Offering Expenses
Direct offering expenses
Long-Lived Tangible Asset [Axis]
Other Accrued Liabilities Current
Other expenses
Document Transition Report
Document Transition Report
Aveo oncology.
A V E O Oncology [Member]
AVEO Oncology
Integrated Diagnostics, Inc.
Integrated Diagnostics Inc [Member]
Integrated Diagnostics, Inc
Deferred Tax Assets Property Plant And Equipment
Property and equipment
Proceeds From Stock Options Exercised
Proceeds from exercise of stock options
Proceeds from exercise of stock options
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
Weighted Average Exercise Price, Forfeited/canceled
Letter of Credit
Letter of Credit [Member]
Short Term Debt Type [Axis]
Short-term Debt, Type
Two thousand six plan two thousand sixteen plan and two thousand twenty equity incentive plan.
Two Thousand Six Plan Two Thousand Sixteen Plan And Two Thousand Twenty Equity Incentive Plan [Member]
2006 Plan, 2016 Plan and 2020 Equity Incentive Plan
Research And Development Expense
Research and development
Research and Development Expense, Total
Intangible Assets Gross Excluding Goodwill
Intangible assets, Cost
Intangible Assets, Gross (Excluding Goodwill), Total
Business combination contingent consideration shares.
Business Combination Contingent Consideration Shares
Contingent consideration shares
Contract With Customer Liability Noncurrent
Non-current deferred revenue
Defined contribution plan.
Defined Contribution Plan Name Extensible List
Defined Contribution Plan Name [Extensible List]
2026
Operating Leases, Future Minimum Payments, Due in Five Years
2026
Finite-Lived Intangible Asset, Expected Amortization, Year Five
Commitment shares issuable on conditional basis
Commitment Shares Issuable on Conditional Basis
Commitment shares issuable on conditional basis.
Dividends Common Stock
Dividends
Dividends, Common Stock, Total
Allocated Share Based Compensation Expense
Total pre-tax share-based compensation expense
Stock compensation expense
Disclosure of accounting policy for approval of amended and restated certificate of incorporation.
Approval Of Amended And Restated Certificate Of Incorporation Policy [Text Block]
Approval of Amended and Restated Certificate of Incorporation
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Purchases
Additions
December two thousand and nineteen convertible notes.
December Two Thousand And Nineteen Convertible Notes [Member]
December 2019 Notes
Area of leased premised obligated to pay base rent
Area of leased premised obligated to pay base rent.
Concentration Risk By Benchmark [Axis]
Concentration Risk Benchmark
Stock issuable per day, value
Sale of Stock, Stock Issuable Per Day, Value
Sale of Stock, stock issuable per day, value.
Statement Of Financial Position [Abstract]
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
Expected dividend yield
Prior to First Anniversary
Debt Instrument Redemption Period One [Member]
First Tranche
Accrued clinical trial expense current.
Accrued Clinical Trial Expense Current
Accrued clinical trial expense
Collateral Held [Domain]
Percentage of conversion price per share of convertible preferred stock.
Percentage Of Conversion Price Per Share Of Convertible Preferred Stock
Percentage of conversion price per share of preferred stock
Series D Preferred Stock [Member]
Series D Preferred Stock
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
Federal statutory income tax rate
Stockholders Equity [Abstract]
Stockholders' equity
Goodwill And Intangible Assets Intangible Assets Policy
Intangible Assets
Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
Reductions for tax positions related to prior years
Gross proceeds from sale of common shares
Proceeds from Issuance or Sale of Equity
Proceeds from Issuance or Sale of Equity, Total
Shares issued as commitment fee
Sale of Stock, Shares Issued as Commitment Fee
Sale of stock, shares issued as commitment fee.
Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Period Increase Decrease
Reclassification of warrant liability to additional paid-in capital, warrants
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Period Increase (Decrease), Total
Warrants And Rights Note Disclosure [Abstract]
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
Changes in fair value
Conversion of preferred stock into common stock.
Conversion Of Preferred Stock Into Common Stock
Conversion of preferred stock into common stock
Up-front Payment Arrangement [Member]
Up Front Cash Payments
Schedule Of Earnings Per Share Basic And Diluted Table [Text Block]
Schedule of Computation of Basic and Diluted Net Loss per Share Attributable to Common Stockholders
Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
Weighted Average Exercise Price, Exercised
Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised
Exercised, warrants
Primary sources of revenue, description
Primary Sources Of Revenue Description
Primary sources of revenue description.
Long Term Debt Maturities Repayments Of Principal In Year Four
2025
Purchased technology.
Purchased Technology [Member]
Purchased Technology
Patents [Member]
Patents
Increase Decrease In Operating Capital [Abstract]
Changes in operating assets and liabilities:
Put option liability current.
Put Option Liability Current
Put option liability
Estimated value of put option liability
Entity Common Stock, Shares Outstanding
Entity Common Stock Shares Outstanding
Common Stock Capital Shares Reserved For Future Issuance
Number of shares reserved for issuance
Fair Value By Measurement Frequency [Axis]
Measurement Frequency
Award Type [Axis]
Award Type
Entity Shell Company
Entity Shell Company
Sale Of Stock Price Per Share
Common stock price per share
Liabilities And Stockholders Equity [Abstract]
Liabilities and Stockholders' Equity
ICFR Auditor Attestation Flag
Icfr Auditor Attestation Flag
Entity Incorporation, State or Country Code
Entity Incorporation State Country Code
Issuance of common stock under employee stock purchase plan
Stock Issued During Period, Value, Employee Stock Purchase Plan
Net Loss per Common Share
Earnings Per Share [Text Block]
Repurchase Agreement Counterparty Name [Domain]
Counterparty Name
Nsclc poc trial.
N S C L C P O C Trial [Member]
NSCLC POC Trial
Fair Value Measurement [Domain]
Liabilities Noncurrent [Abstract]
Non‑current liabilities
Common stock issuable, committed to purchase
Stock Issuable During Period, Value, Committed Shares
Stock issuable during period, value, committed shares.
2021 Term Loan Amendment
Two Thousand Twenty One Term Loan Amendment [Member]
Two Thousand Twenty One Term Loan Amendment.
Amendment Flag
Amendment Flag
Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt
Conversion of convertible debt into common stock upon initial public offering
Schedule Of Stock By Class [Table]
Schedule Of Stock By Class [Table]
Product Or Service [Axis]
Product and Service
Conversion Of Stock Amount Converted1
Conversion of convertible notes and accrued interest into common stock
Schedule Of Finite Lived Intangible Assets [Table]
Schedule Of Finite Lived Intangible Assets [Table]
Share based compensation arrangements by share based payment award non options exercises in period weighted average exercise price.
Share Based Compensation Arrangements By Share Based Payment Award Non Options Exercises In Period Weighted Average Exercise Price
Weighted average exercise price, Exercised, warrants
Other Nonoperating Income Expense
Total other expense
Increase Decrease In Contract With Customer Liability
Deferred revenue
Cash and cash equivalents
Cash And Cash Equivalents At Carrying Value
Cash and cash equivalents
Cash and Cash Equivalents, at Carrying Value, Total
Cash and Cash Equivalents, at Carrying Value, Beginning Balance
Cash and Cash Equivalents, at Carrying Value, Ending Balance
Other (expense) income, net
Other Nonoperating Income
New Accounting Pronouncements Policy Policy [Text Block]
Recently Issued Accounting Standards Not Yet Adopted
Percentage of minimum revenue requirement
Percentage Of Minimum Revenue Requirement
Percentage of minimum revenue requirement.
Operating Leases Rent Expense Net
Rent expense
Operating Leases, Rent Expense, Net, Total
Lease term
Lessee, Operating Lease, Lease Not yet Commenced, Term of Contract
Trademarks [Member]
Trademarks
Long Term Debt
Total
Fair Value Measurements Recurring [Member]
Fair Value, Recurring
Subsequent Events
Subsequent Events [Text Block]
Repayments Of Debt
Repayments of Debt
Prepayment fee waived amount
Prepayment fee waived amount.
Amortization Of Debt Discount Premium
Amortization of convertible notes debt discount
Antidilutive Securities Name [Domain]
Antidilutive Securities, Name
Property Plant And Equipment [Line Items]
Property Plant And Equipment [Line Items]
Other Assets Noncurrent
Other long-term assets
Other Assets, Noncurrent, Total
Medicare.
Medicare [Member]
Medicare
Employee Stock [Member]
Employee Stock Purchase Plan
Type Of Arrangement [Axis]
Collaborative Arrangement and Arrangement Other than Collaborative
Segment Geographical [Domain]
Geographical
Name Of Major Customer [Domain]
Customer
Series A-1 preferred stock.
Series A1 Preferred Stock [Member]
Series A-1 Preferred Stock
Oncimmune Limited.
Oncimmune Limited [Member]
Oncimmune Limited
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
Aggregate Intrinsic Value, Outstanding - Exercisable - December 31, 2021
Schedules Of Concentration Of Risk By Risk Factor [Text Block]
Summary of Revenue and Accounts Receivable by Third-party Payors and Other Customers
Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
Additions for tax positions related to prior years
Subsidiary Sale Of Stock [Axis]
Sale of Stock
Debt instrument back-end facility fee percentage.
Debt Instrument Back End Facility Fee Percentage
Debt instrument, back-end facility fee
Finite Lived Intangible Assets Major Class Name [Domain]
Finite-Lived Intangible Assets, Major Class Name
Fair Value Disclosures [Text Block]
Fair Value
Schedule Of Carrying Values And Estimated Fair Values Of Debt Instruments Table [Text Block]
Summary of Fair Value of Outstanding Borrowings
Proceeds from the sale of common shares
Proceeds from the issuance of common stock
Net proceeds